FI763529A - - Google Patents

Info

Publication number
FI763529A
FI763529A FI763529A FI763529A FI763529A FI 763529 A FI763529 A FI 763529A FI 763529 A FI763529 A FI 763529A FI 763529 A FI763529 A FI 763529A FI 763529 A FI763529 A FI 763529A
Authority
FI
Finland
Application number
FI763529A
Other languages
Finnish (fi)
Inventor
Pierre Baudet
Jean-Paul Ricard
Adrian Schulthess
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/fr
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of FI763529A publication Critical patent/FI763529A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
FI763529A 1976-01-08 1976-12-08 FI763529A (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (it) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
FI763529A true FI763529A (it) 1977-07-09

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763529A FI763529A (it) 1976-01-08 1976-12-08

Country Status (18)

Country Link
JP (1) JPS5285139A (it)
BG (1) BG27537A3 (it)
CA (1) CA1075708A (it)
DD (1) DD128400A5 (it)
DE (1) DE2654951A1 (it)
EG (1) EG12290A (it)
ES (1) ES453795A1 (it)
FI (1) FI763529A (it)
FR (1) FR2337552A1 (it)
GB (1) GB1572035A (it)
GR (1) GR61818B (it)
IL (1) IL51039A0 (it)
NL (1) NL7613457A (it)
PL (1) PL117246B1 (it)
PT (1) PT65894B (it)
RO (1) RO70355A (it)
SE (1) SE7613426L (it)
YU (1) YU286476A (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (nl) * 1979-04-25 1985-05-01 Shell Int Research Werkwijze voor de bereiding van een aromatisch koolwaterstofmengsel door katalytische omzetting van een mengsel van koolmonoxyde en waterstof.

Also Published As

Publication number Publication date
FR2337552A1 (fr) 1977-08-05
PL117246B1 (en) 1981-07-31
PL194851A1 (pl) 1979-05-07
GB1572035A (en) 1980-07-23
DD128400A5 (de) 1977-11-16
CA1075708A (en) 1980-04-15
SE7613426L (sv) 1977-07-09
GR61818B (en) 1979-01-22
RO70355A (ro) 1981-08-17
PT65894B (fr) 1978-05-18
DE2654951A1 (de) 1977-07-21
BG27537A3 (en) 1979-11-12
PT65894A (fr) 1976-12-01
EG12290A (en) 1979-06-30
IL51039A0 (en) 1977-02-28
YU286476A (en) 1982-08-31
NL7613457A (nl) 1977-07-12
ES453795A1 (es) 1978-01-16
JPS5285139A (en) 1977-07-15

Similar Documents

Publication Publication Date Title
CS186526B1 (it)
CH605105A5 (it)
BG23287A1 (it)
BG23177A1 (it)
BG23240A1 (it)
BG23250A2 (it)
BG23277A1 (it)
CH606592A5 (it)
BG23359A1 (it)
BG23436A1 (it)
BG26865A1 (it)
CH575859A5 (it)
CH606668A5 (it)
CH598074A5 (it)
CH598142A5 (it)
BE850978A (it)
CH599373A5 (it)
CH600135A5 (it)
CH600257A5 (it)
CH600574A5 (it)
CH600792A5 (it)
CH605143A5 (it)
CH600990A5 (it)
CH602320A5 (it)
DD127202A1 (it)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: LABORATOIRES OM S.A.